- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04457635
Effect of a 'Rapid-Return-to-work Program' in Mild Mental Disorders.
June 30, 2020 updated by: Aage Indahl, The Hospital of Vestfold
Effect of a 'Rapid-Return-to-work Program' in Mild Mental Disorders. A Randomized Controlled Trial.
This study is a pragmatic randomized controlled trial (RCT) evaluating the effect of brief versus short psychotherapy in subjects with substantial mental complaints.
Study Overview
Detailed Description
Running evaluations of the brief intervention (BI) at our outpatient clinic preceding to this study had given us the impression that the patients obtained a more active coping style towards their health problems with consequential enhanced work participation (WP).
These evaluations, in addition to our experiences in BI for low back pain (LBP) has generated the current hypothesis of this study towards WP.
Yet, the sustainability of WP and long-term effects on mental health remained questionable.
In this pragmatic RCT the objective was to compare brief psychotherapy with focus on normalization and coping (Brief-PsT) with short-term psychotherapy of standard duration with more extended focus (Short-PsT), as otherwise used at the Mental Health services.
The primary aim of this study was to assess differences in effect on WP and the secondary aim was to assess differences in clinical response.
The investigators hypothesized that in the short term, Brief-PsT could facilitate or sustain WP in a superior fashion to Short-PsT in persons who are on, or at risk of sick leave due to mental health problems.
Although the investigators expected a substantial long-term rate of clinical recovery and reduction in mental health-related symptoms in both groups, the investigators had no specific hypothesis regarding the extent and direction of possible group differences in these clinical measurements.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 67 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 'mental complaints' was the main reason for referral to the outpatient clinic
- employed and on or at risk of sick leave
Exclusion Criteria:
- acute or severe pathology that required greater input than the clinic could offer,
- Sick-leave had > 9 months during the preceding 2 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Brief psychotherapy (brief PsT)
The focus was on normalizing, accepting and coping with their present mental health complaints and their hindrance for work participation.
Primarily, there was no intention to process previous pathogenic experiences.
The standard duration was set on six sessions.
|
|
Active Comparator: Short psychotherapy (short-PsT)
With more extended focus, there was besides coping of mental health and challenges concerning WP, an emphasis on both an extensive anamnesis and possibility to establish a so-called central theme based on previous or current challenging issues such as trauma, difficult childhood conditions, and personality-related issues.
Additional aims of the intervention could include reducing symptoms and problematic behaviour and an improvement of home situation, with deeper focus on cognitive maladaptive coping strategies or dynamic repetitions.
The number of sessions was aimed to be 20 on average
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Return to Work (RTW) to 3 months follow-up
Time Frame: baseline - 3 months
|
Transitions from baseline to 3 months follow-up in Work Participation degree
|
baseline - 3 months
|
Change in Return to Work (RTW) to 1 year follow-up
Time Frame: baseline - 1 year
|
Transitions from baseline to 1 year follow-up in Work Participation degree
|
baseline - 1 year
|
Change in Return to Work (RTW) to 2 year follow-up
Time Frame: baseline - 2 year
|
Transitions from baseline to 2 year follow-up in Work Participation degree
|
baseline - 2 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical recovery
Time Frame: 2 years
|
A minimal score on both Beck Inventories (BDI ≤ 13 and BAI ≤ 9)
|
2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Beck Depression Index - II (BDI)
Time Frame: baseline, 2 year follow-up
|
Score 0-63, higher scores mean worse outcome
|
baseline, 2 year follow-up
|
Beck Anxiety Index (BAI)
Time Frame: baseline, 2 year follow-up
|
Score 0-63, higher scores mean worse outcome
|
baseline, 2 year follow-up
|
Hopkins Symptoms Checklist-10
Time Frame: baseline, 2 year follow-up
|
Score 1-4, higher scores mean worse outcome
|
baseline, 2 year follow-up
|
Subjective health complaints (SHC)
Time Frame: baseline, 2 year follow-up
|
Score 0-29, higher scores mean worse outcome
|
baseline, 2 year follow-up
|
Self-efficacy (GSES)
Time Frame: baseline - 2 year follow-up
|
Score 1-4 , lower scores means worse outcome
|
baseline - 2 year follow-up
|
Lfe satisfaction (LISAT)
Time Frame: baseline - 2 year follow-up
|
Score 1-6, lower scores means worse outcome
|
baseline - 2 year follow-up
|
Illness perception (bIPC)
Time Frame: baseline - 2 year follow-up
|
Score 1-10, higher scores mean worse outcome
|
baseline - 2 year follow-up
|
Fear avoidance beliefs -work (FABQ-work)
Time Frame: baseline - 2 year follow-up
|
Score 0-7, higher scores mean worse outcome
|
baseline - 2 year follow-up
|
Global Perceived Effect
Time Frame: 2 year follow-up
|
Score 0-7, lower scores means worse outcome
|
2 year follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Aage Indahl, Prof.Dr, Vestfol Hospital Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2013
Primary Completion (Actual)
September 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
June 26, 2020
First Submitted That Met QC Criteria
June 30, 2020
First Posted (Actual)
July 7, 2020
Study Record Updates
Last Update Posted (Actual)
July 7, 2020
Last Update Submitted That Met QC Criteria
June 30, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HVestfold
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorder
-
Vincent AgyapongNova Scotia Health Authority; Dalhousie UniversityRecruitingGeneralized Anxiety Disorder | Major Depressive Disorder | Mental Health Wellness 1Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Brigham and Women's HospitalRecruitingDepression | Mood Disorders | Depressive Disorder, Major | Psychiatric Disorder | Mental DisorderUnited States
-
Queen's UniversityCompleted
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Brigham and Women's HospitalNot yet recruitingDepression | PTSD | Mood Disorders | Anxiety Disorders | OCD | Major Depressive Disorder | Psychiatric Disorder | Mental Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
University of OuluCompletedSeasonal Affective Disorder (SAD)Finland
-
H. Lundbeck A/SCompletedMajor Depression DisorderGermany, United States, Estonia, Finland, Poland
-
GlaxoSmithKlineCompleted
Clinical Trials on Psychotherapy
-
Universidade Federal do Rio de JaneiroCompleted
-
Randi UlbergUniversity of OsloCompleted
-
Hopital MontfortThe Ottawa HospitalCompletedDepression | Parkinson's DiseaseCanada
-
Marianne Lau, MD, DSci.The Ministry of Science, Technology and Innovation, DenmarkUnknownBulimia Nervosa (BN) | Binge Eating Disorder (BED) | Eating Disorder Not Otherwise Specified (EDNOS)Denmark
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed
-
University Hospital FreiburgCompletedChronic Major Depressive DisorderGermany
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityUnknown
-
Memorial Sloan Kettering Cancer CenterUniversity of Manitoba; National Cancer Institute (NCI); Visiting Nurse Service... and other collaboratorsCompleted
-
Centre Hospitalier Régional Metz-ThionvilleCentral Hospital, Nancy, France; University of LorraineCompletedBreast Cancer FemaleFrance
-
Weill Medical College of Cornell UniversityUnknownIdentity Pathology | Behavior ProblemsUnited States